Very soon, AMBS could have: Commercialized Diag
Post# of 30028
Commercialized Diagnostic for Alzheimer's generating revenue
3 Orphan Drug Designations in the US (1 in Europe?)
Started a Clinical Trial for Eltoprazine
Started a Clinical Trial for ESS-W
Moved to the Nasdaq
Does not sound like an .08 stock for very long...it is all coming together...